Back to search

Article

Expansion of tumor-infiltrating lymphocytes with substantial stem cell properties from vulvar cancer

2021-09-13

Abstract excerpt

Tumor-infiltrating lymphocyte (TIL) therapy has been clinically proved as a promising therapeutic approach for patients with solid tumor. TIL therapy could effectively control tumor growth in cervical cancer as indicated by a phase 2 pivotal trial with an objective response rate of 44.4%. Vulvar cancer is believed to share a similar biological and immunological phenotype with cervical cancer. However, the therapeu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3d92dd3b-70dc-5dd8-a409-ab31ba524d71
DOI
10.22541/au.163155045.52606364/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Expansion of tumor-infiltrating lymphocytes with substantial stem cell properties from vulvar cancerDOI 10.22541/au.163155045.52606364/v1
Select a neighboring publication to make it the new centre.